Potential advantages, disadvantages, and special clinical considerations in the older hypertensive related to the major antihypertensive classes recommended for initial treatment
Table 40.3. Potential advantages, disadvantages, and special clinical considerations in the older hypertensive related to the major antihypertensive classes recommended for initial treatment.
Antihypertensive class | Potential advantages | Potential disadvantages | Clinical situations to recommend use | Clinical situations to recommend against use, or that require monitoring |
Diuretics | Benefit documented in clinical trials Produce greater reduction in SBP than DBP Inexpensive | Metabolic abnormalities Urinary incontinence | Systolic hypertension | Glucose intolerance, gout, hyperlipidemia |
Calcium antagonists | Benefit documented in clinical trials Absence of CNS or metabolic effects | Peripheral edema, constipation, heart block | Systolic hypertension Coronary artery disease | Left ventricular dysfunction |
β-Antagonists | Benefit documented in clinical trials | May increase peripheral vascular resistance Metabolic abnormalities CNS effects | Coronary artery disease and postmyocardial infarction | COPD, peripheral vascular disease, heart block, glucose intolerance, type 2 DM, hyperlipidemia, depression |
ACE inhibitors | Absence of CNS or metabolic effects | Hyperkalemia, renal insufficiency, cough | Congestive heart failure, type 2 DM | Renal insufficiency or renal artery stenosis |
SBP, systolic blood pressure; DBP, diastolic blood pressure; ACE, angiotensin-converting enzyme; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; CNS, central nervous system.